About the Company
We do not have any company description for Intra-Cellular Therapies, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ITCI News
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
In the assessment of 12-month price targets, analysts unveil insights for Intra-Cellular Therapies, presenting an average ...
Intra-Cellular Therapies Prices Public Offering of Common Stock
Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study
Intra-Cellular Therapies Inc (NASDAQ:ITCI) unveiled on Tuesday topline results from Study 501 evaluating lumateperone 42 mg ...
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
Intra-Cellular Therapies, Inc. ITCI announced positive top-line results from its late-stage study evaluating lumateperone 42 ...
Why Intra-Cellular Therapies Is Rising In Pre-market?
Intra-Cellular Therapies, Inc. (ITCI) reported positive topline results from Study 501 evaluating lumateperone 42 mg as an adjunctive ...
Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
Positive results from two Intra-Cellular Therapies phase 3 studies show lumateperone's potential as adjunctive therapy for ...
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the ...
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...
Intra-Cellular Therapies Prices Public Offering of Common Stock
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and ...
Loading the latest forecasts...